Hikma Pharmaceuticals USA Inc. recalls

7 federal recalls on file, showing the 3 from the last 12 months. We read every CPSC, FDA, USDA and NHTSA notice for Hikma Pharmaceuticals USA Inc. and put it in plain English.

Recent recalls

  • Hikma ciprofloxacin tablets recalled for N-nitroso-ciprofloxacin above limit

    Hikma Pharmaceuticals USA Inc. is recalling 29,085 bottles of Ciprofloxacin Tablets, USP, 500 mg, 100-count. The FDA found N-nitroso-ciprofloxacin levels above its recommended interim control limit, a problem under current good manufacturing practice (CGMP) rules. No injuries have been reported.

    ModerateFDANov 3, 20262 products

  • Abirtega abiraterone acetate recalled for failed weight uniformity

    Hikma Pharmaceuticals is recalling Abirtega (abiraterone acetate) 250 mg tablets due to failed weight uniformity specifications. Lot 3047 (expiring July 2027) does not meet quality standards. The issue was identified during quality testing; no injuries have been reported.

    ModerateFDAOct 23, 2026

  • Hikma ramipril capsules recalled for failed impurity specification

    Hikma Pharmaceuticals is recalling specific lots of Ramipril Capsules 10 mg because testing found higher-than-allowed levels of dicyclohexylurea, a process impurity. The affected lots are AC5470A and AC5470B, both expiring July 2027. No injuries have been reported.

    ModerateFDASep 2, 2026

Explore other recall topics

Hikma Pharmaceuticals USA Inc. Recall Alerts | Recall Weekly